BRD4 and cholangiocarcinoma: In cholangiocarcinoma cells, ARV-825 has been shown to significantly upregulate protein 21 expression in the G1 phase and prevent cell cycle progression, leading to the rapid and sustained degradation of BRD4 in cholangiocarcinoma [35].